HPV vaccine : can we afford to hesitate?
| dc.contributor.author | Richter, Karin Louise | |
| dc.contributor.author | Dreyer, Greta | |
| dc.contributor.author | Lindeque, B. Gerhard | |
| dc.contributor.author | Botha, M.H. | |
| dc.contributor.email | karin.richter@up.ac.za | en_ZA |
| dc.date.accessioned | 2015-05-20T09:04:14Z | |
| dc.date.available | 2015-05-20T09:04:14Z | |
| dc.date.issued | 2014-08 | |
| dc.description.abstract | Cervical cancer, caused by human papillomavirus (HPV) infection, is highly prevalent in sub-Saharan Africa. The estimated annual incidence of cervical cancer is 35/100 000 women, with 22.5/100 000 associated deaths. This is in stark contrast to the 6.6/100 000 cases and 2.7/100 000 deaths reported in developed countries such as the USA, where HPV vaccination has been available since 2006. | en_ZA |
| dc.description.librarian | am2015 | en_ZA |
| dc.description.uri | http://www.samj.org.za | en_ZA |
| dc.identifier.citation | Richter, KL, Dreyer, G, Lindeque, BG & Botha, MH 2014, 'HPV vaccine : can we afford to hesitate?', South African Medical Journal, vol. 104, no. 8, pp. 522-523. | en_ZA |
| dc.identifier.issn | 0256-9574 (print) | |
| dc.identifier.issn | 2078-5135 (online) | |
| dc.identifier.other | 10.7196/SAMJ.8449 | |
| dc.identifier.uri | http://hdl.handle.net/2263/45190 | |
| dc.language.iso | en | en_ZA |
| dc.publisher | Health and Medical Publishing Group | en_ZA |
| dc.rights | © 2014 Health & Medical Publishing Group. This work is licensed under a Creative Commons Attribution-NonCommercial Works License (CC BY-NC 3.0). | en_ZA |
| dc.subject | Cervical canver | en_ZA |
| dc.subject | HPV vaccine | en_ZA |
| dc.subject | Human papillomavirus (HPV) | en_ZA |
| dc.subject | Vaccination | en_ZA |
| dc.title | HPV vaccine : can we afford to hesitate? | en_ZA |
| dc.type | Article | en_ZA |